Does aging promote immunosenescence, inflammation, impaired debris clearance, and autoantibody formation?

Aging is associated with interconnected immune changes that favor immunosenescence, persistent inflammation, defective handling of dying cells, and autoreactive antibody production. These processes vary substantially with infection history, comorbidity, adiposity, and tissue context, but the overall direction is well supported.

Immune aging and inflammation

• Thymic involution reduces naïve T-cell output and receptor diversity, while terminally differentiated populations accumulate. T-cell receptor sequencing found age-associated clonal expansion >100-fold in phenotypically naïve CD8⁺ cells and >10-fold in naïve CD4⁺ cells versus younger adults.
• Chronic low-grade inflammation (“inflammaging”) is reflected by higher IL-6, CRP, and often TNF-α in older adults. Over 9 years, each doubling of CRP and IL-6 predicted incident physical or cognitive impairment (odds ratios 1.29 and 1.45, respectively).

Debris clearance and mechanistic links

• Macrophage efferocytosis—the removal of apoptotic cells—declines with age. Aged mice show reduced apoptotic-cell uptake, and macrophages from adults >50 years have lower phagocytosis, migration, and chemotaxis.
• Impaired MerTK/TIM-4 phosphatidylserine recognition, increased CD47 antiphagocytic signaling, and defective autophagic/lysosomal processing can leave apoptotic material uncleared. Secondary necrosis and inflammatory-content release may activate macrophage STING pathways and delay inflammatory resolution, sustaining inflammaging.
• Senescent-cell SASP signaling and mitochondrial danger signals further activate innate inflammatory and inflammasome pathways.

Self-tolerance and autoantibodies

• Reduced thymic selection, impaired regulatory control, altered B-cell negative selection/signaling, and accumulation of autoreactivity-prone age-associated B cells weaken tolerance. Among adults ≥60, 32% had at least one measured rheumatoid-factor, thyroid, or transglutaminase autoantibody.
• Autoantibody positivity does not itself establish pathogenic autoimmune disease.

Bottom line

• The claim is supported: aging promotes these mutually reinforcing immune changes and increases susceptibility to autoantibodies, though individual autoimmunity risk requires antibody- and clinical-context-specific interpretation.